Abstract
The aim of this study is to investigate the frequency and the clinical correlations of pseudobulbar affect (PBA) in a population-based incident cohort of ALS patients. Incident ALS cases, diagnosed in 2011 and 2012, according to El Escorial criteria were enrolled from a prospective population-based registry in Apulia, Southern Italy. Neurological status was assessed using a standard neurological examination and the revised ALS Functional Rating Scale (ALSFRSr). The Center for Neurologic Study-Lability Scale (CNS-LS), a self-administered questionnaire, was used to evaluate the presence and severity of PBA. Total scores range from 7 to 35. A score ≥13 was used to identify the presence of PBA. One-hundred thirty-two sporadic incident ALS cases were enrolled. Median disease duration was 20 months (range 2–143), median onset-diagnosis interval (ODI) 12 months (range 2–131), median ALSFRSr at baseline 36/48 (range 2–47) and median ALSFRSr bulbar sub-score 10/12 (range 0–12). Neurological examination revealed presence of PBA in 34/132 patients (26 %). Pathological CNS-LS score was found in 45/132 patients (34 %). Median total CNS-LS score was 9/35 (range 7–29). The subgroup with pathological CNS-LS was characterized by a short disease duration from symptom onset, ODI, time to diffusion to a second region, time to generalization and ALSFRSr bulbar sub-score, bulbar onset, “definite” diagnostic category, bulbar upper motor-neuron involvement and presence of PBA at neurological examination. In population-based setting, one-third of ALS patients present PBA at diagnosis. The presence of PBA is associated with bulbar UMN involvement and markers of a more severe phenotype.
Similar content being viewed by others
References
Dark FL, McGrath JJ, Ron MA (1996) Pathological laughing and crying. Aust N Z J Psychiatry 30:472–479
Starkstein SE, Migliorelli R, Tesón A et al (1995) Prevalence and clinical correlates of pathological affective display in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 59:55–60
Miller RG, Rosenberg JA, Gelinas DF et al (1999) Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force. Neurology 52:1311–1323
Miller RG, Jackson CE, Kasarskis EJ et al (2009) Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 73:1227–1233
Gallagher JP (1989) Pathologic laughter and crying in ALS: a search for their origin. Acta Neurol Scand 80:114–117
Work SS, Colamonico JA, Bradley WG, Kaye RE (2011) Pseudobulbar affect: an under-recognized and under-treated neurological disorder. Adv Ther 28(7):586–601
Floeter MK, Katipally R, Kim MP et al (2014) Impaired corticopontocerebellar tracts underlie pseudobulbar affect in motor neuron disorders. Neurology 83(7):620–627
Lichtner V, Dowding D, Esterhuizen P et al (2014) Pain assessment for people with dementia: a systematic review of systematic reviews of pain assessment tools. BMC Geriatr 14(1):138
Moore SR, Gresham LS, Bromberg MB, Kasarkis EJ, Smith RA (1997) A self report measure of affective lability. J Neurol Neurosurg Psychiatry 63:89–93
Robinson RG, Parikh RM, Lipsey JR, Starkstein SE, Price TR (1993) Pathological laughing and crying following stroke: validation of a measurement scale and a double-blind treatment study. Am J Psychiatry 150(2):286–293
Brooks BR (1994) El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial “Clinical limits of amyotrophic lateral sclerosis” workshop contributors. J Neurol Sci 124(Suppl):96–107
Logroscino G, Beghi E, Zoccolella S et al (2005) SLAP registry. Incidence of amyotrophic lateral sclerosis in Southern Italy: a population-based study. J Neurol Neurosurg Psychiatry 76:1094–1098
Cedarbaum JM, Stambler N, Malta E et al (1999) The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 169:13–21
Newsom-Davis IC, Abrahams S, Goldstein LH, Leigh PN (1999) The emotional lability questionnaire: a new measure of emotional lability in amyotrophic lateral sclerosis. J Neurol Sci 169(1–2):22–25
Ravits J, Laurie P, Fan Y, Moore DH (2007) Implications of ALS focality: rostral-caudal distribution of lower motor neuron loss postmortem. Neurology 68:1576–1582
Polymenidou M, Cleveland DW (2011) The seeds of neurodegeneration: prion-like spreading in ALS. Cell 147(3):498–508
Logroscino G, Traynor BJ, Hardiman O, EURALS et al (2008) Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. J Neurol Neurosurg Psychiatry 79(1):6–11
Palmieri A, Abrahams S, Sorarù G et al (2009) Emotional lability in MND: relationship to cognition and psychopathology and impact on caregivers. J Neurol Sci 278(1–2):16–20
Montuschi A, Iazzolino B, Calvo A et al (2015) Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy. J Neurol Neurosurg Psychiatry 86(2):168–173
Phukan J, Elamin M, Bede P et al (2012) The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study. J Neurol Neurosurg Psychiatry 83(1):102–108
Consonni M, Iannaccone S, Cerami C et al (2013) The cognitive and behavioural profile of amyotrophic lateral sclerosis: application of the consensus criteria. Behav Neurol 27(2):143–153
McCullagh S, Moore M, Gawel M, Feinstein A (1999) Pathological laughing and crying in amyotrophic lateral sclerosis: an association with prefrontal cognitive dysfunction. J Neurol Sci 169(1–2):43–48
Parvizi J, Coburn KL, Shillcutt SD, Coffey CE, Lauterbach EC, Mendez MF (2009) Neuroanatomy of pathological laughing and crying: a report of the American Neuropsychiatric Association Committee on Research. J Neuropsychiatry Clin Neurosci 21(1):75–87
Pioro EP, Brooks BR, Cummings J, Safety, Tolerability, and Efficacy Results Trial of AVP-923 in PBA Investigators et al (2010) Dextromethorphan plus ultra low-dose quinidine reduces pseudobulbar affect. Ann Neurol. 68(5):693–702
Seliger GM, Hornstein A (1989) Serotonin, fluoxetine, and pseudobulbar affect. Neurology 39(10):1400
Schoedel KA, Pope LE, Sellers EM (2012) Randomized open-label drug-drug interaction trial of dextromethorphan/quinidine and paroxetine in healthy volunteers. Clin Drug Investig 32(3):157–169
Wortzel HS, Oster TJ, Anderson CA, Arciniegas DB (2008) Pathological laughing and crying: epidemiology, pathophysiology and treatment. CNS Drugs 22(7):531–545
Colamonico J, Formella A, Bradley W (2012) Pseudobulbar affect: burden of illness in the USA. Adv Ther 29(9):775–798
Brooks BR, Crumpacker D, Fellus J, Kantor D, Kaye RE (2013) PRISM: a novel research tool to assess the prevalence of pseudobulbar affect symptoms across neurological conditions. PLoS ONE 8(8):e72232
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
European Community’s Seventh Framework Programme (FP7/2007-2013 under Grant agreement 259867).
Conflicts of interest
All authors declare no conflict of interest.
Ethical standards
The study was approved by the Institutional Review Board of Azienda Ospedaliera Universitaria Consorziale Policlinico di Bari.
Rights and permissions
About this article
Cite this article
Tortelli, R., Copetti, M., Arcuti, S. et al. Pseudobulbar affect (PBA) in an incident ALS cohort: results from the Apulia registry (SLAP). J Neurol 263, 316–321 (2016). https://doi.org/10.1007/s00415-015-7981-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-015-7981-3